Legal Representation
Attorney
Norman J. Rich
USPTO Deadlines
Application History
36 eventsDate | Code | Type | Description |
---|---|---|---|
Jul 24, 2017 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Jul 24, 2017 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Nov 29, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 26, 2016 | EX5G | S | SOU EXTENSION 5 GRANTED |
Nov 21, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 21, 2016 | EXT5 | S | SOU EXTENSION 5 FILED |
Jun 16, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 15, 2016 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jun 12, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
May 13, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 13, 2016 | EXT4 | S | SOU EXTENSION 4 FILED |
Nov 19, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 18, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Nov 18, 2015 | EX3G | S | SOU EXTENSION 3 GRANTED |
Nov 9, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 9, 2015 | EXT3 | S | SOU EXTENSION 3 FILED |
May 30, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
May 29, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
May 29, 2015 | EX2G | S | SOU EXTENSION 2 GRANTED |
Apr 29, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Apr 29, 2015 | EXT2 | S | SOU EXTENSION 2 FILED |
Mar 24, 2015 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Mar 24, 2015 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Oct 24, 2014 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Oct 22, 2014 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Oct 22, 2014 | EXT1 | S | SOU EXTENSION 1 FILED |
Oct 22, 2014 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jun 17, 2014 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Apr 22, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION |
Apr 22, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 2, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 13, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Mar 6, 2014 | DOCK | D | ASSIGNED TO EXAMINER |
Dec 4, 2013 | MPMK | E | NOTICE OF PSEUDO MARK E-MAILED |
Dec 3, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 22, 2013 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals, namely, prodrugs, protein fusion compounds and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases, cancer, inflammatory diseases, respiratory and infectious diseases, metabolic diseases, blood disorders and autoimmune diseases; Pharmaceutical compounds, namely, prodrugs, protein fusion compounds and chemical derivatives of pharmaceutically active ingredients for the treatment of the aforesaid diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
MEDICAL FUSION
Classification
International Classes
005